---
course_id: 7-341-of-mice-and-men-humanized-mice-in-cancer-research-spring-2015
layout: course_section
menu:
  leftnav:
    identifier: 7e163d7b0bbf2a372c6cf5874f31469c
    name: Readings
    weight: 40
title: Readings
type: course
uid: 7e163d7b0bbf2a372c6cf5874f31469c

---

| WEEK # | TOPICS | READINGS |
| --- | --- | --- |
| 1 |  {{< br >}}{{< br >}} Introduction {{< br >}}{{< br >}} [See the Lecture Summary]({{< baseurl >}}/sections/lecture-summaries#Lsumm1) {{< br >}}{{< br >}}  | No Readings |
| 2 |  {{< br >}}{{< br >}} Of tumor suppressors and oncogenes {{< br >}}{{< br >}} [See the Lecture Summary]({{< baseurl >}}/sections/lecture-summaries#Lsumm2) {{< br >}}{{< br >}}  |  {{< br >}}{{< br >}} Schwab, M., J. Ellison, et al. "[Enhanced Expression of the Human Gene N–myc Consequent to Amplification of DNA may Contribute to Malignant Progression of Neuroblastoma](http://www.ncbi.nlm.nih.gov/pubmed/6589638)." _Proceedings of the National Academy of Sciences_ 81, no. 15 (1984): 4940–44. {{< br >}}{{< br >}} Baker, S. J., S. Markowitz, et al. "[Suppression of Human Colorectal Carcinoma Cell Growth by Wild–type p53](http://dx.doi.org/10.1126/science.2144057)." _Science_ 249, no. 4971 (1990): 912–15. {{< br >}}{{< br >}}  |
| 3 |  {{< br >}}{{< br >}} Cancer stem cells and minimal residual disease {{< br >}}{{< br >}} [See the Lecture Summary]({{< baseurl >}}/sections/lecture-summaries#Lsumm3) {{< br >}}{{< br >}}  |  {{< br >}}{{< br >}} Lapidot, T., C. Sirard, et al. "[A Cell Initiating Human Acute Myeloid Leukaemia after Transplantation into SCID Mice](http://dx.doi.org/10.1038/367645a0)." _Nature_ 367, no. 6464 (1994): 645–48. {{< br >}}{{< br >}} Gerber, J. M., B. D. Smith, et al. "[A Clinically Relevant Population of Leukemic CD34+CD38– Cells in Acute Myeloid Leukemia](http://dx.doi.org/10.1182/blood-2011-06-364182)." _Blood_ 119, no. 15 (2012): 3571–77. {{< br >}}{{< br >}}  |
| 4 |  {{< br >}}{{< br >}} Can we model human cancers in mice? {{< br >}}{{< br >}} [See the Lecture Summary]({{< baseurl >}}/sections/lecture-summaries#Lsumm4) {{< br >}}{{< br >}}  |  {{< br >}}{{< br >}} Harris, A. W., C. A. Pinkert, et al. "[The E Mu–myc Transgenic Mouse. A Model for High–incidence Spontaneous Lymphoma and Leukemia of Early B Cells](http://dx.doi.org/10.1084/jem.167.2.353)." _The Journal of Experimental Medicine_ 167, no. 2 (1988): 353–71. {{< br >}}{{< br >}} Ishikawa, F., S. Yoshida, et al. "[Chemotherapy–resistant Human AML Stem Cells Home to and Engraft within the Bone–marrow Endosteal Region](http://dx.doi.org/10.1038/nbt1350)." _Nature Biotechnology_ 25, no. 11 (2007): 1315–21. {{< br >}}{{< br >}}  |
| 5 |  {{< br >}}{{< br >}} Making a better Mouse Man—Recent developments in humanized mouse technologies {{< br >}}{{< br >}} [See the Lecture Summary]({{< baseurl >}}/sections/lecture-summaries#Lsumm5) {{< br >}}{{< br >}}  |  {{< br >}}{{< br >}} Shultz, Leonard D., Yoriko Saito, et al. "[Generation of Functional Human T–cell Subsets with HLA–restricted Immune Responses in HLA Class I Expressing NOD/SCID/IL2rγnull Humanized Mice](http://dx.doi.org/10.1073/pnas.1000475107)." _Proceedings of the National Academy of Sciences_ 107, no. 29 (2010): 13022–27. {{< br >}}{{< br >}} Lan, P., N. Tonomura, et al. "[Reconstitution of a Functional Human Immune System in Immunodeficient Mice through Combined Human Fetal Thymus / Liver and CD34+ Cell Transplantation](http://dx.doi.org/10.1182/blood-2005-11-4388)." _Blood_ 108, no. 2 (2006): 487–92. {{< br >}}{{< br >}}  |
| 6 |  {{< br >}}{{< br >}} Sophisticated models of _de novo_ human tumors in humanized mice {{< br >}}{{< br >}} [See the Lecture Summary]({{< baseurl >}}/sections/lecture-summaries#Lsumm6) {{< br >}}{{< br >}}  |  {{< br >}}{{< br >}} Moriya, K., M. Suzuki, et al. "[Development of a Multi–step Leukemogenesis Model of MLL–rearranged Leukemia using Humanized Mice](http://dx.doi.org/10.1371/journal.pone.0037892)." _PLoS One_ 7, no. 6 (2012): e37892. {{< br >}}{{< br >}} Washburn, M. L., M. T. Bility, et al. "[A Humanized Mouse Model to Study Hepatitis C Virus Infection, Immune Response, and Liver Disease.](http://dx.doi.org/10.1053/j.gastro.2011.01.001)" _Gastroenterology_ 140, no. 4 (2011): 1334–44. {{< br >}}{{< br >}}  |
| 7 |  {{< br >}}{{< br >}} Visit to Chen Research Lab {{< br >}}{{< br >}} [See the Lecture Summary]({{< baseurl >}}/sections/lecture-summaries#Lsumm7) {{< br >}}{{< br >}}  | No Readings |
| 8 |  {{< br >}}{{< br >}} The immune system and cancer—Cancer Immunoediting hypothesis {{< br >}}{{< br >}} [See the Lecture Summary]({{< baseurl >}}/sections/lecture-summaries#Lsumm8) {{< br >}}{{< br >}}  |  {{< br >}}{{< br >}} Shankaran, V., H. Ikeda, et al. "[IFN gamma and Lymphocytes Prevent Primary Tumour Development and Shape Tumour Immunogenicity](http://dx.doi.org/10.1038/35074122)." _Nature_ 410, no. 6832 (2001): 1107–11. {{< br >}}{{< br >}} Muul, L. M., P. J., Spiess, et al. "[Identification of Specific Cytolytic Immune Responses against Autologous Tumor in Humans Bearing Malignant Melanoma](http://www.ncbi.nlm.nih.gov/pubmed/3100623)." _Journal of Immunology_ 138, no. 3 (1987): 989–95. {{< br >}}{{< br >}}  |
| 9 |  {{< br >}}{{< br >}} T cell mediated immunotherapy {{< br >}}{{< br >}} [See the Lecture Summary]({{< baseurl >}}/sections/lecture-summaries#Lsumm9) {{< br >}}{{< br >}}  |  {{< br >}}{{< br >}} Attia, P., G. Q. Phan, et al. "[Autoimmunity Correlates with Tumor Regression in Patients with Metastatic Melanoma Treated with Anti–cytotoxic T–Lymphocyte Antigen–4](http://dx.doi.org/10.1200/JCO.2005.06.205)." _Journal of Clnical Oncology_ 23, no. 25 (2005): 6043–53. {{< br >}}{{< br >}} Vudattu, N. K., F. Waldron–Lynch, et al. "[Humanized Mice as a Model for Aberrant Responses in Human T Cell Immunotherapy](http://dx.doi.org/10.4049/jimmunol.1302455)." _Journal of Immunology_ 193, no. 2 (2014): 587–96. {{< br >}}{{< br >}}  |
| 10 |  {{< br >}}{{< br >}} Improving combination chemotherapy and immune–based therapies based on lessons learned from humanized mice {{< br >}}{{< br >}} [See the Lecture Summary]({{< baseurl >}}/sections/lecture-summaries#Lsumm10) {{< br >}}{{< br >}}  |  {{< br >}}{{< br >}} Rambaldi, A., M. Lazzari, et al. "[Monitoring of Minimal Residual Disease after CHOP and Rituximab in Previously Untreated Patients with Follicular Lymphoma](http://dx.doi.org/10.1182/blood.V99.3.856 )." _Blood_ 99, no. 3 (2002): 856–62. {{< br >}}{{< br >}} Pallasch, C. P., I. Leskov, et al. "[Sensitizing Protective Tumor Microenvironments to Antibody–mediated Therapy](http://dx.doi.org/10.1016/j.cell.2013.12.041)." _Cell_ 156, no. 3 (2014): 590–602. {{< br >}}{{< br >}}  |
| 11 |  {{< br >}}{{< br >}} Personalized mice—Part 1: Mouse Avatars {{< br >}}{{< br >}} [See the Lecture Summary]({{< baseurl >}}/sections/lecture-summaries#Lsumm11) {{< br >}}{{< br >}}  |  {{< br >}}{{< br >}} Villarroel, M. C., N. V. Rajeshkumar, et al. "[Personalizing Cancer Treatment in the Age of Global Genomic Analyses: _PALB2_ Gene Mutations and the Response to DNA Damaging Agents in Pancreatic Cancer](http://dx.doi.org/10.1158/1535-7163.MCT-10-0893)." _Molecular Cancer Therapeutics_ 10, no. 1 (2011): 3–8. {{< br >}}{{< br >}} Garralda, E., K. Paz, et al. "[Integrated Next–generation Sequencing and Avatar Mouse Models for Personalized Cancer Treatment](http://dx.doi.org/10.1158/1078-0432.CCR-13-3047)." _Clinical Cancer Research_ 20, no. 9 (2014): 2476–84. {{< br >}}{{< br >}}  |
| 12 |  {{< br >}}{{< br >}} Personalized mice—Part 2: Co–clinical trials {{< br >}}{{< br >}} [See the Lecture Summary]({{< baseurl >}}/sections/lecture-summaries#Lsumm12) {{< br >}}{{< br >}}  |  {{< br >}}{{< br >}} Chen, Z., K. Cheng, et al. "[A Murine Lung Cancer Co–clinical Trial Identifies Genetic Modifiers of Therapeutic Response](http://dx.doi.org/10.1038/nature10937)." _Nature_ 483, no. 7391 (2012): 613–17. {{< br >}}{{< br >}} Chen, Z., E. Akbay, et al. "[Co–clinical Trials Demonstrate Superiority of Crizotinib to Chemotherapy in _ALK_–rearranged Non–small Cell Lung Cancer and Predict Strategies to Overcome Resistance](http://dx.doi.org/10.1158/1078-0432.CCR-13-1733)." _Clinical Cancer Research_ 20, no. 5 (2014): 1204–11. {{< br >}}{{< br >}}  |
| 13 |  {{< br >}}{{< br >}} Class presentation and course evaluation {{< br >}}{{< br >}} [See the Lecture Summary]({{< baseurl >}}/sections/lecture-summaries#Lsumm13) {{< br >}}{{< br >}}  | No Readings